Smith & Nephew plc (LON:SN) Given Average Rating of “Hold” by Brokerages

Shares of Smith & Nephew plc (LON:SN) have been assigned an average recommendation of “Hold” from the six ratings firms that are currently covering the company, MarketBeat Ratings reports. Four research analysts have rated the stock with a hold recommendation and two have issued a buy recommendation on the company. The average twelve-month price objective among brokers that have issued a report on the stock in the last year is GBX 1,381.33.

SN has been the subject of several recent analyst reports. JPMorgan Chase & Co. reaffirmed an “overweight” rating on shares of Smith & Nephew in a research report on Friday, November 7th. Berenberg Bank restated a “hold” rating and set a GBX 1,300 price objective on shares of Smith & Nephew in a research report on Friday, January 23rd. Panmure Gordon reaffirmed a “hold” rating and set a GBX 1,200 target price on shares of Smith & Nephew in a research note on Tuesday, December 9th. Royal Bank Of Canada downgraded Smith & Nephew to a “sector perform” rating and dropped their target price for the company from GBX 1,700 to GBX 1,350 in a report on Wednesday, December 17th. Finally, Citigroup raised their price target on shares of Smith & Nephew from GBX 1,450 to GBX 1,600 and gave the stock a “buy” rating in a report on Friday, October 31st.

Smith & Nephew Stock Performance

LON SN opened at GBX 1,371.50 on Friday. The company has a debt-to-equity ratio of 70.22, a quick ratio of 0.84 and a current ratio of 2.51. The stock has a market cap of £15.04 billion, a PE ratio of 49.38, a price-to-earnings-growth ratio of 0.46 and a beta of 0.62. The business’s fifty day moving average price is GBX 1,258.93 and its 200 day moving average price is GBX 1,303.60.

About Smith & Nephew

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.